Cytodyn Inc (CYDY)

[JPG77]

Thank you, Saltz. With respect to the

powerful DD

, I think you may have me confused with JBEM. I'm one of those who followed JBEM from another board, and his DD is the best that I've seen. My opinion on 2017...I think we'll see the pps gradually increase when P3 mono begins, and then pick up speed as we get closer to P3 adjunct approval because that's when we have the potential to start generating revenue. I also believe enrollment for P3 mono will go much faster than adjunct. In my opinion, 2017 will be the year to accumulate - not trade, and certainly not short. And just to clarify, I don't think we'll ever get to where we're generating revenue because I think there will be a buyout well before then.